These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1442149

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Assessment of antitumor activity rhizoxin for human lung cancer cell lines: a potent new drug for drug-resistant lung cancer].
    Takigawa N, Ohnoshi T, Ueoka H, Horiguchi T, Kiura K, Tabata M, Segawa Y, Shibayama T, Genba K, Matsumura T.
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1221-6. PubMed ID: 8392827
    [Abstract] [Full Text] [Related]

  • 7. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
    Tsuruo T, Yusa K, Sudo Y, Takamori R, Sugimoto Y.
    Cancer Res; 1989 Oct 15; 49(20):5537-42. PubMed ID: 2790778
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antitumor activity of platinum analogs against human lung cancer cell lines and tumor specimens.
    Yonei T, Ohnoshi T, Hiraki S, Ueoka H, Kiura K, Moritaka T, Shibayama T, Tabata M, Segawa Y, Takigawa N.
    Acta Med Okayama; 1993 Aug 15; 47(4):233-41. PubMed ID: 8213217
    [Abstract] [Full Text] [Related]

  • 10. In vitro evaluation of antimicrotubule agents in human small-cell lung cancer cell lines.
    Ikubo S, Takigawa N, Ueoka H, Kiura K, Tabata M, Shibayama T, Chikamori M, Aoe K, Matsushita A, Harada M.
    Anticancer Res; 1999 Aug 15; 19(5B):3985-8. PubMed ID: 10628341
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of 13-hydroxy SM5887 in combination with other anticancer agents on human tumor cell lines.
    Takagi T, Yazawa Y, Suzuki K, Yamauchi Y, Kano Y.
    Invest New Drugs; 1996 Aug 15; 14(4):357-63. PubMed ID: 9157070
    [Abstract] [Full Text] [Related]

  • 18. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
    Watanabe M, Komeshima N, Naito M, Isoe T, Otake N, Tsuruo T.
    Cancer Res; 1991 Jan 01; 51(1):157-61. PubMed ID: 1988080
    [Abstract] [Full Text] [Related]

  • 19. [Establishment of adriamycin-resistant human small-cell lung cancer cells in culture: analysis of the mechanism of resistance and cross-resistance].
    Kimura I, Ohnoshi T, Hiraki S, Miyamoto H.
    Gan To Kagaku Ryoho; 1987 Mar 01; 14(3 Pt 2):830-6. PubMed ID: 3032107
    [Abstract] [Full Text] [Related]

  • 20. [New anthracycline analogues in the treatment of lung cancer].
    Ueoka H, Ohnoshi T, Kimura I.
    Gan To Kagaku Ryoho; 1992 Nov 01; 19(13):2146-9. PubMed ID: 1332624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.